SMTL ID : 8gmn.2 (3 other biounits)

Crystal structure of human C1s in complex with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 1 residues within 4Å: Chain A: K.258 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:K.258

1 x ZWK: [4-(1-aminophthalazin-6-yl)piperazin-1-yl](2-methylphenyl)methanone(Non-covalent)

ZWK.2: 14 residues within 4Å: Chain A: P.141, H.158, D.309, S.310, C.311, K.312, S.315, V.336, S.337, W.338, G.339, Q.341, C.342, G.346 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:P.141, A:V.336 Hydrogen bonds: A:D.309, A:S.310 Water bridges: A:T.344, A:L.347 pi-Stacking: A:H.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ikeda, Z. et al., Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway. J.Med.Chem. (2023)

Release Date

2023-05-17

Peptides

Complement C1s subcomponent: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Complement C1s subcomponent

Related Entries With Identical Sequence